-
New Global Research Effort Aims to Accelerate Progress in Parkinson’s Disease
April 28, 2026
… A major expanded global research effort is underway to better understand Parkinson’s disease and move us closer … 32 new Collaborative Research Network (CRN) team grants, representing more than $261 million in new investment. These … insights and progress in real time, working as a global community to move research forward faster. “For patients …
-
2023-07-27 MJFF Ltr to VA Sec on TCE exposure as presumed connection to Parkinson's.pdf
… 2023-07-27 MJFF Ltr to VA Sec on TCE exposure as presumed connection to Parkinson's.pdf …
-
Targets to Therapies Annual Meeting Launches Next Wave of Parkinson’s Drug Targets
March 31, 2026
… convened the first-ever annual meeting of its Targets to Therapies (T2T) initiative, bringing together more than … to a virtual format, the energy and engagement of the T2T community were undeterred. Across plenary sessions and … between biology and therapeutic opportunity. MJFF also previewed early work with an AI-enabled workflow to support …
-
This Clinical Trial Participant Isn't One to 'Sit on the Sidelines'
March 20, 2014
… searches, and thought it could be carpal tunnel. After many visits to the doctor and wearing a brace on his wrist, a … the study. That little white pill box went with him everywhere, even on vacations. Inspired by his experience, Brian … that they can go ask questions to learn more before ever committing to participating. Brian said he’ll check out any …
-
Pum2-mediated Translational Regulation of Alpha-synuclein mRNA Associated with Mitochondria
… of the protein alpha-synuclein and dysfunction of mitochondria (the powerhouse of the cell) are two critical components of Parkinson’s disease. We have recently found … of studies address the molecular mechanisms governing expression control of alpha-synuclein. Our study will bring …
-
Delivery of Kinase-Modified LRRK2 to Dopaminergic Neurons Using High-Capacity Viral Vectors
… of the disease. Our work has demonstrated that the most common mutations found in PD cases activate the enzymatic … will determine whether this enzymatic activity is required to recapitulate the neurodegeneration found in PD cases in pre-clinical models of disease. Project Description: In …